{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:04:08Z","timestamp":1782281048930,"version":"3.54.5"},"posted":{"date-parts":[[2026,1,20]]},"group-title":"Microbiology","reference-count":60,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,20]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>Ebola virus (EBOV) typically results in a severe\u2014and often lethal\u2014acute disease. However, increasing evidence suggests that EBOV can persist in certain immune-privileged tissues, which may then serve as reservoirs for the later reemergence of EBOV and disease recrudescence. Here, we report atypical EVD recrudescence in a ferret model inoculated with an otherwise lethal dose of EBOV and treated with low doses of a highly potent monoclonal antibody cocktail. Among 32 antibody-treated ferrets, 14 animals survived, while 8 succumbed to acute EVD within about 5-8 days. The remaining 10 animals succumbed to atypical EVD between 12 and 18 days post-infection (DPI) despite having shown no, or very minor, signs of illness during the acute phase of disease. While viremia disappeared by 14 DPI in most animals that succumbed to atypical EVD, it rebounded modestly just prior to death. Unlike animals that died of acute EVD, those that died of atypical EVD showed only a moderate systemic inflammatory response and few signs of organ dysfunction, in line with low levels of virus in the liver and spleen. Interestingly, however, ferrets that died of atypical EVD showed high levels of virus in the brain, consistent with increased markers of inflammation in the central nervous system and significant pathological changes, including a breakdown in the blood-brain barrier and severe meningoencephalitis. Not only does this study shed important light on the atypical and underappreciated manifestations of EVD, but it also establishes the ferret as a valuable model of EBOV persistence and recrudescence.<\/jats:p>\n                <jats:sec>\n                  <jats:title>AUTHOR SUMMARY<\/jats:title>\n                  <jats:p>Over the last several years, it has become increasingly apparent that Ebola virus is capable of persisting in survivors and, occasionally, reemerging to cause a recrudescent disease that is often distinct from the acute illness and characterized by neurological involvement. Since nearly all existing Ebola virus animal models are uniformly lethal, it has been difficult to understand the processes that lead to persistence and atypical manifestations of disease. In this study, we describe a late-onset, atypical Ebola virus disease in ferrets that was characterized by high levels of virus in the brain and significant markers of brain inflammation. Our comprehensive analysis of the pathogenic processes that contributed to this disease not only provides critical insight into Ebola virus persistence and recrudescence, but it also establishes the ferret as the first tractable model for investigating these atypical outcomes.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.01.20.700506","type":"posted-content","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:15:11Z","timestamp":1768965311000},"source":"Crossref","is-referenced-by-count":0,"title":["Characterization of Atypical Ebola Virus Disease in Ferrets"],"prefix":"10.64898","author":[{"given":"Wenguang","family":"Cao","sequence":"first","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"He","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Schulz","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Wight","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chan","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Emeterio","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Liu","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Audet","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Tierney","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Azaransky","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Frost","sequence":"additional","affiliation":[{"name":"Mycobacteriology, Vector-Borne and Prion Diseases Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilianne","family":"Gee","sequence":"additional","affiliation":[{"name":"Mass Spectrometry and Proteomics Core, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McQueen","sequence":"additional","affiliation":[{"name":"Mass Spectrometry and Proteomics Core, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chong","sequence":"additional","affiliation":[{"name":"Mass Spectrometry and Proteomics Core, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Booth","sequence":"additional","affiliation":[{"name":"Mycobacteriology, Vector-Borne and Prion Diseases Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Westmacott","sequence":"additional","affiliation":[{"name":"Mass Spectrometry and Proteomics Core, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA"},{"name":"Deptartment of Medicine, University of California San Diego, La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiankun","family":"Zeng","sequence":"additional","affiliation":[{"name":"United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-2648","authenticated-orcid":false,"given":"Logan","family":"Banadyga","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada"},{"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026020607500579000_2026.01.20.700506v1.1","unstructured":"Kuhn JH , Amarasinghe GK , Perry DL. Filoviridae. In: Peter M. Howley DMK , Sean Whelan , editor. Fields Virology: Wolters Kluwer; 2021."},{"key":"2026020607500579000_2026.01.20.700506v1.2","first-page":"372","article-title":"The Ebola outbreak, 2013-2016: old lessons for new epidemics","volume":"2017","year":"1721","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2026020607500579000_2026.01.20.700506v1.3","unstructured":"Organization WH. Ebola virus disease: Democratic Republic of the Congo: External Situation Report 98. 2020 June 23, 2020."},{"key":"2026020607500579000_2026.01.20.700506v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0147-3"},{"issue":"15","key":"2026020607500579000_2026.01.20.700506v1.5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJMoa1511410","article-title":"Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"2026020607500579000_2026.01.20.700506v1.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw601"},{"key":"2026020607500579000_2026.01.20.700506v1.7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600378"},{"key":"2026020607500579000_2026.01.20.700506v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/vew016"},{"issue":"10","key":"2026020607500579000_2026.01.20.700506v1.9","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1016\/S2214-109X(16)30175-9","article-title":"Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data","volume":"4","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2026020607500579000_2026.01.20.700506v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw078"},{"key":"2026020607500579000_2026.01.20.700506v1.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw202"},{"issue":"17","key":"2026020607500579000_2026.01.20.700506v1.12","first-page":"479","article-title":"Possible sexual transmission of Ebola virus - Liberia, 2015","volume":"64","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026020607500579000_2026.01.20.700506v1.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509773"},{"key":"2026020607500579000_2026.01.20.700506v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy280"},{"key":"2026020607500579000_2026.01.20.700506v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30386-5"},{"key":"2026020607500579000_2026.01.20.700506v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500306"},{"issue":"3","key":"2026020607500579000_2026.01.20.700506v1.17","doi-asserted-by":"crossref","first-page":"e1012065","DOI":"10.1371\/journal.ppat.1012065","article-title":"Ebola virus disease sequelae and viral persistence in animal models: Implications for the future","volume":"20","year":"2024","journal-title":"PLoS Pathog"},{"issue":"5","key":"2026020607500579000_2026.01.20.700506v1.18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/acsinfecdis.7b00266","article-title":"Small Animal Models for Evaluating Filovirus Countermeasures","volume":"4","year":"2018","journal-title":"ACS Infect Dis"},{"key":"2026020607500579000_2026.01.20.700506v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw209"},{"key":"2026020607500579000_2026.01.20.700506v1.20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01033-16"},{"issue":"1","key":"2026020607500579000_2026.01.20.700506v1.21","first-page":"62","article-title":"The Ferret as a Model for Filovirus Pathogenesis and Countermeasure Evaluation","volume":"61","year":"2022","journal-title":"ILAR J"},{"issue":"10","key":"2026020607500579000_2026.01.20.700506v1.22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/17460441.2024.2386100","article-title":"An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses","volume":"19","year":"2024","journal-title":"Expert Opin Drug Discov"},{"issue":"10","key":"2026020607500579000_2026.01.20.700506v1.23","doi-asserted-by":"crossref","first-page":"100905","DOI":"10.1016\/S2666-5247(24)00137-X","article-title":"Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study","volume":"5","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026020607500579000_2026.01.20.700506v1.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024670"},{"key":"2026020607500579000_2026.01.20.700506v1.25","doi-asserted-by":"crossref","unstructured":"Banadyga L , Zhu W , Kailasan S , Howell KA , Franaszek K , He S , et al. Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop. mBio. 2021;12(1).","DOI":"10.1128\/mBio.01438-20"},{"key":"2026020607500579000_2026.01.20.700506v1.26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw257"},{"key":"2026020607500579000_2026.01.20.700506v1.27","doi-asserted-by":"publisher","DOI":"10.1086\/520589"},{"issue":"Suppl 7","key":"2026020607500579000_2026.01.20.700506v1.28","first-page":"S617","article-title":"Atypical Ebola Virus Disease in a Rhesus Macaque","volume":"228","year":"2023","journal-title":"J Infect Dis"},{"key":"2026020607500579000_2026.01.20.700506v1.29","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3776-09.2009"},{"key":"2026020607500579000_2026.01.20.700506v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.02.023"},{"key":"2026020607500579000_2026.01.20.700506v1.31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006605"},{"key":"2026020607500579000_2026.01.20.700506v1.32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi5229"},{"key":"2026020607500579000_2026.01.20.700506v1.33","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1038\/nmicrobiol.2017.113","article-title":"Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys","volume":"2","year":"2017","journal-title":"Nat Microbiol"},{"key":"2026020607500579000_2026.01.20.700506v1.34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.721328"},{"issue":"24","key":"2026020607500579000_2026.01.20.700506v1.35","doi-asserted-by":"crossref","first-page":"e0083321","DOI":"10.1128\/JVI.00833-21","article-title":"Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye","volume":"95","year":"2021","journal-title":"J Virol"},{"key":"2026020607500579000_2026.01.20.700506v1.36","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.23684"},{"key":"2026020607500579000_2026.01.20.700506v1.37","doi-asserted-by":"crossref","unstructured":"Orosz SE , Johnson-Delaney CA . Disorders of the Nervous System. In: Johnson-Delaney CA , editor. Ferret Medicine and Surgery. Boca Raton, Florida: CRC Press; 2017.","DOI":"10.1201\/9781315371504"},{"issue":"5","key":"2026020607500579000_2026.01.20.700506v1.38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/irv.12273","article-title":"Chimeric antibodies with extended half-life in ferrets","volume":"8","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"2026020607500579000_2026.01.20.700506v1.39","unstructured":"Administration USFaD. Integrated Review: BLA-761169 Inmazeb (Atoltivimab, Maftivimab, and odesivimab-ebgn). 2020 2020\/10\/14."},{"key":"2026020607500579000_2026.01.20.700506v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30397-9"},{"key":"2026020607500579000_2026.01.20.700506v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)30036-4"},{"issue":"2","key":"2026020607500579000_2026.01.20.700506v1.42","first-page":"275","article-title":"Sudan Virus Persistence in Immune-Privileged Organs of Nonhuman Primate Survivors","volume":"31","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"2026020607500579000_2026.01.20.700506v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22132-0"},{"key":"2026020607500579000_2026.01.20.700506v1.44","doi-asserted-by":"crossref","unstructured":"Cross RW , Bornholdt ZA , Prasad AN , Woolsey C , Borisevich V , Agans KN , et al. Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease. JCI Insight. 2022;7(10).","DOI":"10.1172\/jci.insight.159090"},{"key":"2026020607500579000_2026.01.20.700506v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03901-9"},{"issue":"12","key":"2026020607500579000_2026.01.20.700506v1.46","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3201\/eid2212.160847","article-title":"Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014-2015","volume":"22","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2026020607500579000_2026.01.20.700506v1.47","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","year":"1938","journal-title":"American Journal of Hygiene"},{"key":"2026020607500579000_2026.01.20.700506v1.48","doi-asserted-by":"crossref","first-page":"114348","DOI":"10.1016\/j.jviromet.2021.114348","article-title":"Optimisation of methodology for whole genome sequencing of Measles Virus directly from patient specimens","volume":"299","year":"2022","journal-title":"J Virol Methods"},{"key":"2026020607500579000_2026.01.20.700506v1.49","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2024."},{"issue":"42","key":"2026020607500579000_2026.01.20.700506v1.50","first-page":"1686","article-title":"Welcome to the tidyverse","volume":"4","year":"2019","journal-title":"Journal of Open Source Software"},{"key":"2026020607500579000_2026.01.20.700506v1.51","unstructured":"DeBerardine M. BRGenomics: Tools for the Efficient Analysis of High-Resolution Genomics Data. 1.17.1 ed2023."},{"key":"2026020607500579000_2026.01.20.700506v1.52","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026020607500579000_2026.01.20.700506v1.53","unstructured":"Kolde R. pheatmap: Pretty Heatmaps. 1.0.12 ed2019."},{"key":"2026020607500579000_2026.01.20.700506v1.54","unstructured":"Wickham H , Fran\u00e7ois R , Henry L , M\u00fcller K , Vaughan D. dplyr: A Grammar of Data Manipulation. 1.1.4 ed2023."},{"key":"2026020607500579000_2026.01.20.700506v1.55","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp328"},{"key":"2026020607500579000_2026.01.20.700506v1.56","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.TIR119.001616"},{"key":"2026020607500579000_2026.01.20.700506v1.57","first-page":"520","article-title":"Proteome-wide identification of ubiquitin interactions using UbIA-MS","volume":"13","year":"2018","journal-title":"Nature Protocols"},{"key":"2026020607500579000_2026.01.20.700506v1.58","unstructured":"Wickham H , Bryan J. readxl: Read Excel Files. 1.4.3 ed2023."},{"key":"2026020607500579000_2026.01.20.700506v1.59","unstructured":"Wickham H. stringr: Simple, Consistent Wrappers for Common String Operations. 1.5.1 ed2023."},{"issue":"1","key":"2026020607500579000_2026.01.20.700506v1.60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-023-00685-z","article-title":"The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs","volume":"8","year":"2023","journal-title":"NPJ Vaccines"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.20.700506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:14:27Z","timestamp":1782278067000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.01.20.700506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":60,"URL":"https:\/\/doi.org\/10.64898\/2026.01.20.700506","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1371\/journal.ppat.1013916","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,1,20]]},"subtype":"preprint"}}